EndoSure Test vs Laparoscopy

For the estimated 1.5 million women in the UK living with endometriosis, diagnosis has historically required surgery. Laparoscopy – a surgical procedure performed under general anaesthesia – has long been considered the gold standard for confirming endometriosis. While it remains a valuable tool, it comes with drawbacks: surgical risk, recovery time, and NHS waiting lists that can stretch to months and even years.

The EndoSure Test offers a new pathway. As the first non-invasive, rapid diagnostic test for diagnosing endometriosis, it enables healthcare professionals to detect the condition accurately – without surgery, without anaesthesia, and without delay.

EndoSure & Laparoscopy Comparison

Below, we have created a comparison of the EndoSure Test and Laparoscopy.

EndoSure Test Laparoscopy
Invasiveness Non-invasive – no incisions or instruments Surgical – 2–3 abdominal incisions required
Anaesthesia None required General anaesthesia required
Procedure time Less than 60 minutes 1 – 3 hours
Recovery time None – return to normal activity immediately 1 – 2 weeks off work and normal activity
Hospital stay No hospital admission required Day case or overnight stay
Results Results available same day During or shortly after the procedure
Detects all stages Yes – Stages I through IV Yes – gold standard for staging
Accuracy Highly accurate non-invasive diagnostic test 50-75% accurate when used to diagnose Disease
Risk None Surgical risks: bleeding, infection, organ damage
Suitable for Any patient, and for follow up evaluation to evaluate treatment or surgical results Patients where surgical confirmation is required
NHS waiting time Available privately – immediate access Significant NHS waiting lists – often 1 – 3+ years
Patient experience Comfortable, sensor-based, no discomfort Post-operative pain, bruising and fatigue

An Important Clinical Note

It is important to recognise that laparoscopy remains the definitive confirmatory procedure for endometriosis and is essential where surgical intervention is required. The EndoSure Test is designed to work alongside – not replace – the clinical pathway. Its value lies in providing rapid, non-invasive diagnostic data earlier in the patient journey, reducing unnecessary delays, and helping clinicians prioritise and plan next steps with greater confidence, and evaluate treatment success.

For patients who have waited years for a diagnosis, the EndoSure Test represents a meaningful step forward in how endometriosis is identified and managed in the UK.